Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination therapy used for controlled ovarian stimulation in assisted reproductive technologies such as IVF and IUI. This protocol combines clomiphene citrate, an oral selective estrogen receptor modulator that stimulates ovulation, with recombinant follicle stimulating hormone, which directly stimulates follicular development. The combination aims to achieve effective ovarian stimulation while potentially reducing gonadotropin dosage requirements, minimizing monitoring needs, and lowering the risk of ovarian hyperstimulation syndrome compared to standard protocols.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on clomiphene citrate + recombinant follicle stimulating hormone.